We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-6.15%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.22B
AUM Growth
-$360M
Cap. Flow
-$44.9M
Cap. Flow %
-2.02%
Top 10 Hldgs %
20.17%
Holding
274
New
20
Increased
66
Reduced
133
Closed
31

Top Buys

1
GH icon
Guardant Health
GH
+$22.9M
2
LTH icon
Life Time Group Holdings
LTH
+$19.4M
3
VSEC icon
VSE Corp
VSEC
+$17.6M
4
ETNB
89bio
ETNB
+$13.6M
5
WSBC icon
WesBanco
WSBC
+$12.3M

Top Sells

1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$36.6M
2
FTAI icon
FTAI Aviation
FTAI
+$17.2M
3
NOG icon
Northern Oil and Gas
NOG
+$15.6M
4
FULT icon
Fulton Financial
FULT
+$14.4M
5
NVEE
NV5 Global
NVEE
+$13.2M

Sector Composition

1 Healthcare 25.67%
2 Technology 23.1%
3 Industrials 18.7%
4 Financials 15.06%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTAI icon
1
FTAI Aviation
FTAI
$20.9B
$52.9M 2.38%
476,579
-145,694
-23% -$17.2M
PLMR icon
2
Palomar
PLMR
$3.56B
$51.6M 2.32%
376,696
-58,347
-13% -$6.91M
CRDO icon
3
Credo Technology Group
CRDO
$38.8B
$49.4M 2.22%
1,229,033
-147,894
-11% -$9.19M
INSM icon
4
Insmed
INSM
$23.3B
$45.3M 2.04%
594,013
-90,623
-13% -$6.93M
KTOS icon
5
Kratos Defense & Security Solutions
KTOS
$8.81B
$43.9M 1.98%
1,477,871
-141,823
-9% -$4.3M
SKWD icon
6
Skyward Specialty Insurance
SKWD
$2.37B
$43.1M 1.94%
814,884
-8,520
-1% -$410K
FRPT icon
7
Freshpet
FRPT
$2.8B
$42.4M 1.91%
509,448
+11,416
+2% +$1.4M
SLNO
8
DELISTED
Soleno Therapeutics
SLNO
$40.3M 1.82%
564,481
-16,438
-3% -$800K
BBIO icon
9
BridgeBio Pharma
BBIO
$15.7B
$39.6M 1.78%
1,145,491
-5,377
-0.5% -$181K
QTWO icon
10
Q2 Holdings
QTWO
$3.48B
$39.5M 1.78%
493,433
+9,119
+2% +$804K
TVTX icon
11
Travere Therapeutics
TVTX
$5.14B
$37.2M 1.68%
2,077,173
-48,571
-2% -$986K
VRNS icon
12
Varonis Systems
VRNS
$5.4B
$36.7M 1.65%
907,065
-18,477
-2% -$795K
CRS icon
13
Carpenter Technology
CRS
$27.5B
$35.9M 1.62%
198,396
-17,467
-8% -$3.37M
BPMC
14
DELISTED
Blueprint Medicines
BPMC
$35.5M 1.6%
401,644
-15,222
-4% -$1.48M
GTLS icon
15
Chart Industries
GTLS
$10B
$35.5M 1.6%
246,037
-3,401
-1% -$626K
AX icon
16
Axos Financial
AX
$5.74B
$34.4M 1.55%
533,586
+54,466
+11% +$3.69M
BWIN
17
Baldwin Insurance Group
BWIN
$2.68B
$33.3M 1.5%
744,621
-122,451
-14% -$4.99M
OLLI icon
18
Ollie's Bargain Outlet
OLLI
$4.05B
$32.6M 1.47%
279,815
+24,993
+10% +$2.64M
RDNT icon
19
RadNet
RDNT
$4.95B
$32.1M 1.44%
645,222
-11,967
-2% -$708K
IDCC icon
20
InterDigital
IDCC
$6.86B
$31.2M 1.41%
151,097
-10,703
-7% -$2.15M
TMDX icon
21
Transmedics
TMDX
$2.63B
$30.6M 1.38%
454,794
+83,083
+22% +$5.71M
ATI icon
22
ATI
ATI
$25.3B
$30.6M 1.38%
587,250
-14,789
-2% -$840K
VITL icon
23
Vital Farms
VITL
$565M
$29.8M 1.34%
978,197
+113,874
+13% +$4.1M
MMSI icon
24
Merit Medical Systems
MMSI
$4.51B
$29.7M 1.34%
280,677
-22,078
-7% -$2.28M
TTMI icon
25
TTM Technologies
TTMI
$13.5B
$29.5M 1.33%
1,439,931
+367,798
+34% +$8.89M
1
2 3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Emerald Advisers held 274 positions worth $2.22B, down 14% from $2.58B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q1 2025 filing shows 20 new, 66 increased, 133 reduced and 31 closed positions. Its largest new stake was Guardant Health: 531,424 shares worth $22.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Emerald Advisers's largest Q1 2025 buy was Guardant Health: 531,424 shares worth $22.6M.
  • Emerald Advisers added most to The Bancorp in Q1 2025, an estimated $11.8M increase.
  • Emerald Advisers's biggest Q1 2025 reduction was FTAI Aviation, cutting an estimated $17.2M.
  • Emerald Advisers fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $36.6M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.22B portfolio in Q1 2025.
  • Emerald Advisers opened 20 new positions and closed 31 in Q1 2025.
  • Emerald Advisers's portfolio value fell 14% quarter-over-quarter to $2.22B.

Based on Emerald Advisers's 13F filing for Q1 2025, filed 1 May 2025.